Skip to main content
Immunotherapy
CAR T-Cell Therapy Targeting Solid Tumors
Chase Doyle
Read More
FDA Updates
Keytruda Approved for Patients with Previously Treated Metastatic Small-Cell Lung Cancer
Yvette Florio Lane
Read More
FDA Updates
First Chemoimmunotherapy Regimen Granted Accelerated Approval for Patients with Previously Treated DLBCL
Yvette Florio Lane
Read More
FDA Updates
Welcome to the Fourth Annual Oncology Guide to New FDA Approvals
Read More
FDA Updates
New Indications Approved by the FDA in 2018 for Oncology Drugs
Dalia Buffery, MA, ABD
Read More
FDA Updates
FDA Approvals of Novel Brand-Name Prescription Cancer Drugs in 2018
Read More
Online Only
FDA Updates, Melanoma
Braftovi (Encorafenib) plus Mektovi (Binimetinib) Third BRAF/MEK Inhibition Combination Approved for Metastatic Melanoma with BRAF Mutation
Lisa A. Raedler, PhD, RPh, Medical Writer
Read More
FDA Updates, Lymphoma
Copiktra (Duvelisib) Approved for Relapsed or Refractory CLL, SLL, and Follicular Lymphoma
Lisa A. Raedler, PhD, RPh, Medical Writer
Read More
Online Only
FDA Updates, Leukemia
Daurismo (Glasdegib) Approved, in Combination with Low-Dose Cytarabine, for Newly Diagnosed Acute Myeloid Leukemia in Older Adults or Those Unfit for Intensive Chemotherapy
Loretta Fala, Medical Writer
Read More
FDA Updates, Gastrointestinal Cancers
Lutathera (Lutetium Lu 177 Dotatate) First Radioactive Drug Approved for Gastroenteropancreatic Neuroendocrine Tumors
Lisa A. Raedler, PhD, RPh, Medical Writer
Read More
Page 152 of 200
Results 1511 - 1520 of 1993